Combination antacid and prokinetic agent

This page covers all Combination antacid and prokinetic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H+/K+-ATPase (PPIs) or H2 receptor (H2RAs); dopamine antagonist or other prokinetic target.

Targets

H+/K+-ATPase (PPIs) or H2 receptor (H2RAs); dopamine antagonist or other prokinetic target

Marketed (1)

• Drug either PPIS or H2RA and prokinetics · King Saud University · Gastroenterology
  This is a combination therapy using either proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2RAs) to reduce gastric acid, paired with prokinetic agents to enhance gastric motility and accelerate gastric emptying.

Patent intelligence

• combination antacid and prokinetic agent patent landscape — aggregated cliff calendar, attackable patents, originator estates